维持性血液透析患者并发恶性肿瘤的研究进展  

Research progress on malignant tumor in patients with maintenance hemodialysis

作　　者：蔡少娜 李彩霞[2] 杜真萍 周丽芳 赵宜娜 陈柯 李莹莹 符霞[2] CAI Shaona;LI Caixia;DU Zhenping;ZHOU Lifang;ZHAO Yina;CHEN Ke;LI Yingying;FU Xia(College of Nursing,Guangdong Pharmaceutical University,Guangdong Province,Guangzhou510006,China;Department of Nursing,the Eighth Affiliated Hospital,Sun Yat-sen University,Guangdong Province,Shenzhen518033,China)

机构地区：[1]广东药科大学护理学院,广东广州510006 [2]中山大学附属第八医院护理部,广东深圳518033

出　　处：《中国医药导报》2025年第1期66-70,共5页China Medical Herald

基　　金：广东省护理学会护理创新发展研究课题(YJYZ 202303);深圳市科技创新委员会基础研究专项项目(JCYJ 20230807111018038);深圳市福田区卫生健康系统重点科研项目(FTWS2023087);中山大学附属第八医院护理科研项目(2024zdbyhlky005)。

摘　　要：维持性血液透析(MHD)是终末期肾病患者的主要治疗方式之一,中国是全球MHD患者数量最多的国家,近年来患者总数持续增加。MHD患者的恶性肿瘤发病率显著高于普通群体,引发国内外医学界的高度关注。本文对MHD患者并发恶性肿瘤的流行病学、影响因素及可干预影响因素的防治策略进行总结,旨在为医务人员实施干预提供一定的理论依据。Maintenance hemodialysis(MHD)is one of the primary treatment methods for patients with end-stage renal disease.China has the largest population of patients with MHD worldwide,and total number of patients has been steadily increasing in recent years.Incidence rate of malignant tumor in patients with MHD is significantly higher than that in general population,attracting considerable attention from medical community both domestically and internationally.This paper summarizes epidemiology,risk factors,and prevention and control strategies of modifiable influencing factors for malignant tumor in patients with MHD,the aim is to provide theoretical basis of health worker for implementing effective intervention.

关 键 词：维持性血液透析 恶性肿瘤 终末期肾病 氧化应激 

分 类 号：R473.73[医药卫生—护理学]